Moneycontrol PRO
HomeNewsOpinionSun Pharma breaks away from pure play generic companies in US

Sun Pharma breaks away from pure play generic companies in US

Sun Pharma’s revenues from specialty drugs surpassed generic medicines for the first time in the US

November 10, 2025 / 08:34 IST
Sun Pharma has several new drugs in the specialty products pipeline.
Unlock This Article

Are you a PRO subscriber? Sign In

What Do You Get

  • Ad free Experience

    Seamless navigation, faster responses.

  • Expert Perspective

    Explore 230+ exclusive editorials every month

  • +

    Uncover Insights from World-Renowned Experts and Journalists

  • Actionable Insights

    40+ weekly investment ideas + 3 to 4 daily technical calls

  • Virtual Events

    Exclusive Live Webinars for Expert Trading & Investment Strategies!

  • Newsletters

    Stay ahead with daily and weekly insights

Unlock exclusive discounts